Loading…
Loading…
Dexcom Inc
NASDAQ · Stock Profile · Market Cap $26.39B
Current Price
$67.66
+0.51%GoodMoat Value
$70.33
3.9% undervaluedDXCM's revenue grew at a 29.2% CAGR over the last 6 years.
Forward estimates use 31.0% FCF growth (CAGR)
Net Debt: 418M
1.0B
FY24
994M
FY24
4.0B
FY24
1.0B
FY25
1.2B
FY25
1.2B
FY25
4.7B
FY25
144M
FY24
135M
FY24
576M
FY24
105M
FY25
180M
FY25
284M
FY25
836M
FY25
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently. Category: IR
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Country
California, USA
DXCM's revenue grew at a 29.2% CAGR over the last 6 years.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →This stock does not currently pay a dividend.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently. Category: IR
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Country
California, USA